Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review paper
Explore by Goal
"Biology is a science of three dimensions. The first is the study of each species across all levels of biological organization, molecule to cell to organism to population to ecosystem. The second dimension is the diversity of all species in the biosphere. The third dimension is the history of each species in turn, comprising both its genetic evolution and the environmental change that drove the evolution."
- E. O. Wilson
Quick Explanation
Copied
BGPT take:
This Primer synthesizes how TEAD1–4 integrate Hippo-node and non-Hippo cues via co-factors (YAP/TAZ, VGLLs, and other TEAD partners) to drive context-dependent transcriptional programs across development, homeostasis, regeneration, and cancer. It is strong as a conceptual map, but—like most Primers—mechanistic resolution is uneven and often depends on heterogeneous primary studies.
Core anchor:
Long Explanation
Paper Review (Primer): TEAD family transcription factors in development and disease
Journal anchor:
Primer type implication: this is not a single new experiment; it is a literature synthesis—so “proof” is replaced by consistency mapping across studies.
1) TEAD signaling logic (conceptual map)
What the Primer claims (synthesis):
TEAD1–4 are sequence-specific DNA-binding transcription factors, but need co-factors for transcriptional output; the Hippo pathway most prominently regulates TEAD activity via controlling nuclear availability of YAP and TAZ.
VGLL family proteins provide a second major TEAD input layer; in several contexts they can either support overlapping gene programs with YAP/TAZ or act antagonistically/with distinct outcomes, emphasizing the context-specific nature of TEAD-cofactor logic.
Beyond YAP/TAZ and VGLLs, the Primer points to additional TEAD partners (e.g., p160 coactivator family proteins and FAM181A/B), implying TEAD transcriptional outputs are not limited to the canonical Hippo axis.
2) Regulatory layers emphasized by the Primer
Evidence anchors for specific layers:
Post-translational / stability: TEAD palmitoylation is described as regulating stability and transcriptional output, including TEAD–Hippo pathway signaling impacts.
Mechanical cues: the Primer emphasizes that cell morphology, stiffness, cytoskeletal tension, and related cues regulate TEAD activity mainly by modulating YAP/TAZ localization and thus TEAD co-activator availability.
Chromatin/epigenetic recruitment: the Primer discusses TEAD/YAP recruitment of epigenetic modifiers and transcriptional complexes (e.g., SWI/SNF, NuRD, Mediator), supporting a model where TEAD activity is integrated into broader chromatin regulatory machinery.
3) Development → tissue contexts (schematic co-factor usage)
Critical note on interpretation: this heatmap is not quantitative biology. It only reflects which co-factor classes the Primer explicitly highlights in the provided text excerpts (e.g., “Tead4–Yap”, “Tead1–Vgll4”, “Tead–Yap/Taz”, etc.).
4) Disease framing: what is well-supported vs uncertain
4A. Cancer
The Primer argues that TEAD dysregulation can contribute to proliferative disease states, and it positions the TEAD–YAP/TAZ complex as a therapeutic target conceptually.
Direct YAP→TEAD mediation is supported by primary mechanistic studies showing TEAD requirement for YAP-induced gene expression and growth (e.g., CTGF as a direct target in the cited mechanistic study).
Skeptical reading: even if YAP→TEAD is necessary for specific gene induction programs (e.g., CTGF in certain systems), TEAD might be system-specific essentiality rather than universal mediator of all YAP phenotypes. The Primer itself acknowledges context dependence and also highlights non-YAP TEAD co-factors, which complicates “one pathway → one disease” narratives.
4B. Examples of direct molecular links outside canonical “Hippo only” logic
Viral perturbation of TEAD activity via host chromatin: HCMV infection can diminish TEAD1 activity through multiple mechanisms involving chromatin accessibility and TEAD1 binding, consistent with TEAD sensitivity to broader genome architecture beyond core Hippo kinases.
Counterpoint / limitation awareness: this is an in vitro infection model (two cell types, one viral strain, one timepoint) so translational generality to in vivo tissues and developmental stages must be tested rather than assumed.
5) What’s scientifically valuable in this Primer
Systems-level integration: TEAD biology is framed as a multi-input integrator (Hippo/YAP/TAZ, VGLL competition, additional partners, PTMs, and mechanics) rather than a single linear pathway.
Research direction clarity: the Primer explicitly highlights key unknowns: upstream control of VGLL1–3, downstream gene program comparisons across TEAD/cofactor combinations, and the need for combined transcriptional/epigenomic profiling for combinations.
6) Skeptical critique: where the synthesis may mislead (or be incomplete)
Heterogeneous evidence and publication bias: as a Primer, it depends on published mechanistic and genetic studies that vary widely in model system, assay sensitivity, and endpoint definition; consistency claims are therefore only as robust as the underlying study diversity and reproducibility.
Context dependence can blur causal generalization: TEAD outputs can depend on co-factor availability, PTM status, and chromatin context; therefore, “TEAD involved in X disease” may not specify which TEAD/cofactor axis and what mechanistic step is causal.
Non-YAP/TAZ TEAD partner functions are less established: while TEAD–FAM181A/B interactions are supported structurally/biochemically, downstream biological roles are still underdetermined (as the Primer notes).
7) Evidence map: TEAD mechanisms the field supports well vs still evolving
Why schematic? the Primer is a synthesis, and this response does not perform a formal quantitative meta-analysis; therefore, the figure is a reasoned qualitative map rooted in the cited examples, not a statistical evidence aggregation.
Primary takeaway (falsifiable implication)
If TEAD output is truly driven by co-factor availability and competition (YAP/TAZ vs VGLLs vs other partners), then perturbations that selectively disrupt one co-factor binding interface should shift TEAD-dependent transcription and phenotypes without equivalently changing TEAD DNA binding alone. Evidence that YAP–TEAD binding is required for YAP-induced gene programs supports this idea in at least some contexts.
Author-specific BGPT reviews
Links to deeper author-focused analyses (per request).
Feedback:
Updated: May 01, 2026
BGPT Paper Review
Study Novelty
80%
As a Primer, it is not “new” experimentally, but it consolidates a relatively modern TEAD-centric view emphasizing co-factor diversity beyond YAP/TAZ (including VGLL competition and additional partners) into a single developmental-to-disease narrative.
Scientific Quality
80%
High-quality synthesis anchored in mechanistic primary literature and explicit open questions; however, as a Primer it cannot resolve contradictions or quantify effect sizes across tissues, and the strength of mechanistic specificity varies by topic. Evidence for at least some mechanistic axes (e.g., YAP–TEAD dependence, TEAD palmitoylation) is strong in cited primary studies.
Study Generality
80%
The cross-tissue framework (development/homeostasis/disease) is broadly informative, and TEAD as a co-factor integration node is a general organizing concept; still, many mechanistic details remain system-specific and the Primer does not provide standardized cross-context quantification.
Study Usefulness
80%
Useful as a roadmap: it identifies major TEAD inputs (YAP/TAZ, VGLLs, PTMs, mechanics, additional partners) and points to specific methodological directions (RNA-seq/ChIP-seq/ATAC-seq comparisons across TEAD/cofactor combinations).
Study Reproducibility
60%
As a Primer, reproducibility depends on the underlying studies rather than new experimental methods; no deposited datasets are provided in the Primer itself.
Explanatory Depth
70%
It provides a coherent systems-level explanation and strong conceptual models (co-factor competition, TEAD regulation layers), but mechanistic depth is uneven across tissues and co-factor partners due to the Primer format.
Build a TEAD↔cofactor↔tissue network from the Primer’s cited examples, then rank mechanistic gaps by evidence tier using the cited primary studies (YAP–TEAD dependence, VGLL competition, TEAD palmitoylation).
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A “TEAD always mirrors YAP targets” strongman model is unlikely: the Primer’s emphasis on VGLL antagonism/distinct roles and additional TEAD partners implies that TEAD programs should vary when co-factor composition changes.
A “viral chromatin remodeling reduces TEAD solely by removing YAP/TAZ” explanation is too narrow: multi-mechanism evidence reports TEAD1 binding/accessibility loss plus altered TEAD1 abundance/splicing in addition to YAP1/pYAP1 changes.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion